Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
RWJ-67657
Cat No.
CEI-1105
Description
RWJ-67657 is a potent, orally active inhibitor of p38 mitogen-activated protein kinase. It selectively inhibits p38α and p38β over p38γ, p38δ and a range of other kinases. RWJ-67657 inhibits the release of TNF-α by lipopolysaccharide (a monocyte stimulus)-treated human peripheral blood mononuclear cells with an IC50 of 3 nM, as well as the release of TNF-α from peripheral blood mononuclear cells treated with the superantigen staphylococcal enterotoxin B (a T cell stimulus), with an IC50 of 13 nM. RWJ-67657 may have use as a treatment for inflammatory diseases.
Abbr
RWJ-67657(MAPK14)
Alias
RP1-179N16.5, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, P38alpha
Product Overview
Inhibitor of p38 mitogen-activated protein kinase
CAS No.
215303-72-3
Molecular Weight
425.5
Purity
> 95%
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
Storage
4 centigrade
Synonyms
RP1-179N16.5, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, P38alpha
Targets
p38 MAP
Molecular Formula
C27H24FN3O
Chemical Name
4-(4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(pyridin-4-yl)-1H-imidazol-2-yl)but-3-yn-1-ol
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Download
Download Datasheet